1. Home
  2. PRTA vs JBSS Comparison

PRTA vs JBSS Comparison

Compare PRTA & JBSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • JBSS
  • Stock Information
  • Founded
  • PRTA 2012
  • JBSS 1959
  • Country
  • PRTA Ireland
  • JBSS United States
  • Employees
  • PRTA N/A
  • JBSS N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • JBSS Specialty Foods
  • Sector
  • PRTA Health Care
  • JBSS Consumer Staples
  • Exchange
  • PRTA Nasdaq
  • JBSS Nasdaq
  • Market Cap
  • PRTA 802.8M
  • JBSS 961.7M
  • IPO Year
  • PRTA N/A
  • JBSS 1991
  • Fundamental
  • Price
  • PRTA $13.77
  • JBSS $88.70
  • Analyst Decision
  • PRTA Buy
  • JBSS
  • Analyst Count
  • PRTA 7
  • JBSS 0
  • Target Price
  • PRTA $57.67
  • JBSS N/A
  • AVG Volume (30 Days)
  • PRTA 448.2K
  • JBSS 81.6K
  • Earning Date
  • PRTA 11-12-2024
  • JBSS 01-29-2025
  • Dividend Yield
  • PRTA N/A
  • JBSS 2.53%
  • EPS Growth
  • PRTA N/A
  • JBSS N/A
  • EPS
  • PRTA N/A
  • JBSS 4.64
  • Revenue
  • PRTA $133,350,000.00
  • JBSS $1,108,874,000.00
  • Revenue This Year
  • PRTA $46.28
  • JBSS N/A
  • Revenue Next Year
  • PRTA N/A
  • JBSS N/A
  • P/E Ratio
  • PRTA N/A
  • JBSS $19.46
  • Revenue Growth
  • PRTA N/A
  • JBSS 13.01
  • 52 Week Low
  • PRTA $12.31
  • JBSS $79.07
  • 52 Week High
  • PRTA $41.55
  • JBSS $108.96
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 43.50
  • JBSS 52.93
  • Support Level
  • PRTA $12.31
  • JBSS $88.62
  • Resistance Level
  • PRTA $14.28
  • JBSS $91.98
  • Average True Range (ATR)
  • PRTA 0.98
  • JBSS 2.09
  • MACD
  • PRTA 0.00
  • JBSS 0.42
  • Stochastic Oscillator
  • PRTA 33.73
  • JBSS 56.27

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

About JBSS John B. Sanfilippo & Son Inc.

John B Sanfilippo & Son Inc is one of the processors and distributors of peanuts, pecans, cashews, walnuts, almonds, and other nuts in the United States. These nuts are sold under a variety of private brands and under the Fisher, Orchard Valley Harvest, and Sunshine Country brand names. It also market and distribute, and in the majority of cases, manufacture or process, a diverse product line of food and snack products, including peanut butter, almond butter, cashew butter, candy and confections, snacks and trail mixes, snack bites, sunflower kernels, dried fruit, corn snacks, sesame sticks and other sesame snack products under private brands and brand names.

Share on Social Networks: